ATOSSA THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 3536000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-09-30) |
| Status | current |
| Entity | ATOSSA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:48:04.568110+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/feaf6e71-f4e0-4237-a053-cf09988e3085
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-25-276160 · Open the official SEC filing →Retrieved: 2026-08-19T14:48:04.568110+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001488039/accounts-payable/2025-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/feaf6e71-f4e0-4237-a053-cf09988e3085
History
- no predecessors — first report